Suepravision Life Sciences Private Limited
About Suepravision Life Sciences Private Limited
Data last updated:
Suepravision Life Sciences Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the csw professional segment of the business services sector. It was incorporated on 10 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36931MH2012PTC238664.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Audumbar Vithal Sawant and Chandrakant Vithal Sawant.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 203 Kalpvruksh Chs Ltd Plot No – 22 Sector – 13 Khandacolony, Navi Mumbai, Maharashtra, India – 410206.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Suepravision Life Sciences Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address203 Kalpvruksh Chs Ltd Plot No – 22 Sector – 13 Khandacolony, Navi Mumbai, Maharashtra, India – 410206
- IndustryBusiness Services, Csw Professional, Scientific And Technical Activities
To see the full contact details of Suepravision Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Suepravision Life Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Suepravision Life Sciences Private Limited, buy the company report.
Financials of Suepravision Life Sciences Private Limited
FY 2025 filings availableSuepravision Life Sciences Private Limited reported revenue of ₹10 for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 54% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suepravision Life Sciences Private Limited, buy the company report.
Board of directors of Suepravision Life Sciences Private Limited
Suepravision Life Sciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Audumbar Vithal Sawant | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
| Chandrakant Vithal Sawant Also directs: Macindia Life Sciences Private Limited | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
| Swati Chandrakant Sawant | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
| Vidya Audumbar Sawant | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
Peer comparison
Suepravision Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| New View Research and Development Private Limited | ₹118 (FY 2025) | Chandrapur, Maharashtra, India | ||||
| Sprygen Biotherapeutics Private Limited | ₹100 (FY 2024) | Bangalore, Karnataka, India | ||||
| Urban Vertical & Integrated Box Ecosystem Private Limited | ₹100 (FY 2020) | Navi Mumbai, Maharashtra, India | ||||
| Suepravision Life Sciences Private Limitedthis company | ₹10 (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Helikem Biotek Industrial Research Private Limited | ₹7 (FY 2025) | -100.0% | Tiruchirappalli, Tamil Nadu, India | |||
| Council for Strategic Affairs | ₹1 (FY 2025) | Rohtak, Haryana, India |
To see the full peer comparison of Suepravision Life Sciences Private Limited, buy the company report.
Auditor
Suepravision Life Sciences Private Limited is audited by SHARDA DHANANJAY GAIKWAD for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHARDA DHANANJAY GAIKWAD | FY 2017 | 150319 |
Shareholding
The shareholding of Suepravision Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Suepravision Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Suepravision Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suepravision Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Suepravision Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Suepravision Life Sciences Private Limited has 4 board changes on record since 2012: 4 appointments. The latest: Audumbar Vithal Sawant was appointed as Director on 10 Dec 2012.
Frequently asked questions
Suepravision Life Sciences is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in csw professional, within the business services industry. It was incorporated on 10 December 2012 (14+ years old) and is registered under CIN U36931MH2012PTC238664.
Suepravision Life Sciences has 4 current directors:
- Audumbar Vithal Sawant - Director
- Chandrakant Vithal Sawant - Director
- Swati Chandrakant Sawant - Director
- Vidya Audumbar Sawant - Director
The latest financial statements of Suepravision Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Suepravision Life Sciences is U36931MH2012PTC238664. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suepravision Life Sciences was incorporated on 10 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Suepravision Life Sciences by revenue are New View Research and Development Private Limited, Sprygen Biotherapeutics Private Limited, Urban Vertical & Integrated Box Ecosystem Private Limited, Helikem Biotek Industrial Research Private Limited, Council for Strategic Affairs, all in the same principal business activity (scientific research and development).
Audumbar Vithal Sawant was appointed as Director on 10 Dec 2012. Chandrakant Vithal Sawant was appointed as Director on 10 Dec 2012. Swati Chandrakant Sawant was appointed as Director on 10 Dec 2012. Suepravision Life Sciences has 4 board changes on record in total.
The registered office of Suepravision Life Sciences is at 203 Kalpvruksh Chs Ltd Plot No – 22 Sector – 13 Khandacolony, Navi Mumbai, Maharashtra, India – 410206.
Suepravision Life Sciences operates in the business services industry, in the csw professional segment.
The compliance status of Suepravision Life Sciences is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Suepravision Life Sciences can be reached at its registered office: 203 Kalpvruksh Chs Ltd Plot No – 22 Sector – 13 Khandacolony, Navi Mumbai, Maharashtra, India – 410206.